Chronic Kidney Disease Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Adults aged 18 or older (male or non-pregnant female) who are expected to live long enough to complete all study visits and procedures.
• People who are willing to sign a consent form before any study data is collected or procedures are performed.
• People who are willing to follow the study requirements, including attending all follow-up appointments.
• People who have permanent, non-reversible kidney failure and are currently on dialysis or are expected to need dialysis within 6 months of the procedure.
• People whose target vein(s) for the procedure measure at least 2.0 mm in diameter, as confirmed by ultrasound or imaging.
• People whose target artery for the procedure measures at least 2.0 mm in diameter, as confirmed by ultrasound or imaging.
• People who, in the opinion of the treating doctor, have adequate blood flow to the hand through surrounding blood vessels.
• People who have at least one suitable surface vein measuring 2.5 mm or more in diameter that connects to the planned treatment site through a specific vein in the upper forearm.

Who may not be able to join:

• People whose blood clots too easily (a hypercoagulable state).
• People who have a known condition that causes unusual or excessive bleeding.
• People whose heart does not pump strongly enough to support a fistula, in the opinion of the treating doctor.
• People with a known history of active intravenous drug use.
• People who have had major surgery within the 30 days before the procedure, or who have a major surgery planned within 6 months after the procedure.
• People who have a known allergy or sensitivity to contrast dye used in imaging that cannot be adequately managed with medication beforehand.
• People who have had known problems with sedation or anaesthesia that cannot be adequately managed with medication beforehand.
• People who show signs of active infection on the day of the procedure, such as a fever of 38.0°C or higher, or an elevated white blood cell count (if tested).
• People who have another medical condition that, in the opinion of the treating doctor, may make it difficult to follow the study, affect the results, or means they are unlikely to live long enough to complete the study.
• People who are currently taking part in another clinical trial for an investigational drug or device that is still ongoing or that could interfere with this study's results.
• People who have a significant narrowing (greater than 50%) of a major vein in the chest on the same side as the planned procedure, based on imaging.
• People who do not have the specific connecting vein in the upper forearm needed for the procedure, as confirmed by ultrasound or imaging.
• People who have a blockage or narrowing of more than 50% in the target surface veins (such as those in the forearm or at the elbow), as confirmed by ultrasound or imaging.
• People who have significantly reduced blood flow in the arm being treated, as determined by the treating doctor and confirmed by ultrasound or imaging.
• People who have significant calcium build-up at the planned procedure site that could affect the success of the procedure, in the opinion of the treating doctor.

Important: Always verify eligibility with the trial site directly before applying.